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We have recently reported that OTOF underlies an autosomal recessive form of prelingual sensorineural deafness,
DFNB9. The isolated 5-kb cDNA predicted a 1,230 amino acid (aa) C-terminus membrane–anchored cytosolic
protein with three C2 domains. This protein belongs to a family of mammalian proteins sharing homology with
the Caenorhabditis elegans fer-1. The two other known members of this family, dysferlin and myoferlin, both have
six predicted C2 domains. By northern blot analysis, a 7-kb otoferlin mRNA could be detected in the human brain.
We isolated the corresponding cDNA, which is expected to encode a 1,977-aa-long form of otoferlin with six C2
domains. A 7-kb cDNA derived from the murine orthologous gene, Otof, was also identified in the inner ear and
the brain. The determination of the exon-intron structure of the human and murine genes showed that they are
composed of 48 coding exons and extend ∼90 kb and ∼80 kb, respectively. Alternatively spliced transcripts could
be detected that predict several long isoforms (six C2 domains) in humans and mice and short isoforms (three C2
domains) only in humans. Primers were designed to explore the first 19 OTOF exons, henceforth permitting
exploration of the complete coding sequence of the gene in DFNB9 patients. In a southwestern Indian family
affected by DFNB9, a mutation in the acceptor splice site of intron 8 was detected, which demonstrates that the
long otoferlin isoforms are required for inner ear function.
Introduction
Deafness is one of the most frequent hereditary disorders
in humans. The vast majority of genetic prelingual hear-
ing loss is inherited on the autosomal recessive mode
(DFNB forms) (for review, see work by Petit [1996]).
To date, 26 DFNB loci have been mapped (see Web site
for Nonsyndromic Hearing Impairment Autosomal Re-
cessive Loci) and six genes have been identified (Kelsell
et al. 1997; Liu et al. 1997; Weil et al. 1997; Li et al.
1998;Wang et al. 1998;Mustapha et al. 1999; Yasunaga
et al. 1999). Using a positional cloning strategy com-
bined to a candidate gene approach, we have identified
the OTOF gene, encoding otoferlin, as responsible for
DFNB9 (MIM 601071) (Yasunaga et al. 1999). The 5-
kb OTOF cDNA from a total fetus polyA mRNA
preparation, encodes a putative 1,230-aa membrane-an-
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chored cytosolic protein containing three predicted C2
domains (Yasunaga et al. 1999) (GenBank AF107403).
A single nonsense mutation has been detected in the four
analyzed Lebanese families. This mutation is predicted
to truncate the 500 C-terminal amino acids of the pro-
tein (Yasunaga et al. 1999). OTOF is a member of a
mammalian gene family related to the Caenorhabditis
elegans gene fer-1 (Achanzar andWard 1997). This fam-
ily also comprises DYSF (Bashir et al. 1998; Liu et al.
1998) andMYOF (Davis et al. 2000), encoding dysferlin
(2080 aa) and myoferlin (2061 aa), respectively. Both
dysferlin and myoferlin are membrane-anchored cyto-
solic proteins that contain six predicted C2 domains,
four of which are expected to bind Ca2 (Rizo and
Su¨dhof 1998). Subsequent detection of a 7-kb otoferlin
mRNA by northern blot analysis prompted us to char-
acterize this transcript which had not been detected in
our initial study.
Subjects and Methods
Northern Blot Analysis
Northern blots of adult human and murine tissues
(Clontech) were incubated with cDNA probes derived
from the 3′-UTR sequences of the otoferlin genes—
namely, positions 6722–7103 (GenBankAF183185) and
6615–7005 (AF183184) for the human and murine
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probes, respectively, in Express Hyb solution (Clontech),
according to the manufacturer’s instructions. The filters
then were exposed to Kodak BioMax X-ray film for 14
d at 80C. The tissues analyzed were human brain,
heart, placenta, lung, liver, pancreas, skeletalmuscle, and
kidney, and murine brain, heart, spleen, lung, liver, skel-
etal muscle, kidney, and testis.
RACE-PCR, RT-PCR, and Long-Range PCR
Oligo-dT and random-primed cDNA libraries were
constructed from poly(A) mRNA of human total fetus,
adult brain, heart, kidney, and murine fetal heart, using
a Marathon cDNA amplification kit (Clontech). RACE-
PCR experiments were performed on these libraries us-
ing linker primers and a series of primers selected from
the otoferlin cDNA sequence. The PCR products were
directly cloned into pGEM-T Easy vector (Promega) and
sequenced. To isolate the human cDNA long form (7
kb), a reverse primer (5′-TTCACCTGGGCCCGCA-
GCATCCT-3′) was designed from the sequence encoding
aa 63–70 of the initially reported short form of otoferlin
(Yasunaga et al. 1999) (GenBank 107403).
Total RNAs were extracted from 2-d-old mouse coch-
lea and brain by the guanidium isothiocyanate procedure.
RT-PCR experiments were performed in various murine
and human RNA sources, according to the GeneAmp
RNA PCR kit protocol (Perkin Elmer Cetus). To recon-
stitute the entire murine cDNAs derived from the brain
and the cochlea, we used two primer pairs, one from the
exon 1 5 ′-UTR (5 ′-AGGCGTGTGAGCCACA-
CTCCACCA-3′) and exon 22 (5′-CATAACCTCA-
GCTTGTCCCGAACA-3′), and the other from the exon
18-19 junction (5′-GGCCCCAGATCACGGACAG-
GAAC-3′) and exon 48 3′-UTR (5′-GGCCAGTACACCT-
GATTCACACT-3′). To reconstitute the entire 5′ part of
the human brain cDNA long form, primers derived from
the 5′-UTR exon 1 (5′-GGAGGAGGCAGCGGCAGA-
GAAGA-3′) and exon 22 (5′-TTCACCTGGGCCCGCA-
GCATCCT-3′) were used. Alternative splicings were also
detected by RT-PCR (see fig. 4). To show the skipping of
exon 6, primers from exon 4 (5′-AATCGGGTAGAGGT-
GACCGACAC-3′) and exon 10 (5′-CCGAGCCTCAAT-
CACTGTGATGC-3′) were selected inmouse, andprimers
from exon 5 (5′-GTGGAGGTCCGGTATCAGGCCAC-
3′) and exon 8 (5′-ACACCGAGTCGGGATCCA-
GTCCA-3′) were designed in humans. To reveal the al-
ternative splicing of exon 31, a primer pair from the
mur in e exon 29 -30 (5 ′ -CAAGTGGTTTGA-
AGTGGACCTCCC-3′) and exon 32-33 (5′-GCCACA-
TCCACCTTGACCACAGC-3′) junctions was used, both
in mice and in humans, as the human and murine se-
quences were identical. Finally, to show the alternative
splicing of exon 47, primers from exon 44 (5′-
GGAGTCTATGTTCTCCTGGGATGAGAC-3′) and
exon 48 3′-UTR (5′-GTCTTGCTCAAGGCTGGC-
AGGCG-3′) and from exon 45 (5′-GACAGCCAAGCA-
GTGCACCATGG-3′) and exon 48 3′-UTR (5′-AGGCA-
GGCTCGGCCCAAGGCATG-3′) were chosen in mice
and in humans, respectively. Long-range PCR was per-
formed using Expand Long Template PCR Systems. PCR
primers with a predicted melting temperature (Tm) of
72C were designed, and a two-step PCR procedure (35
cycles of 92–94C for 15 sec and 68C for 4–30 min) was
adopted.
Patients
The consanguineous family J2 originates from south-
western India (Maharashtra state). All members were
subjected to clinical investigation, including a general
examination and audiometric tests. Audiometrywas per-
formed with a pure-tone, portable audiometer. Affected
individuals demonstrated severe-to-profound prelingual
sensorineural hearing impairment.
Genotyping and Linkage Analysis
Informed consent was obtained from all individuals
(Consultative Committee for People Protection in Bio-
medical Research in France and IRB approval nr OH93-
DC-0116 in the USA). Genotyping was carried out using
a set of primer pairs amplifying three polymorphicmark-
ers from the DFNB9 chromosomal region (D2S174,
D2S2350, and D2S2223) (Yasunaga et al. 1999). A mul-
tipoint LOD score of 2.4 was obtained for family J2.
Mutation Detection
Each of the 48 OTOF coding exons was PCR am-
plified on 50 ng of genomic DNA, using the primers
described in table 1 for exons 1–19, and in table 2 (Ya-
sunaga et al. 1999) for exons 20–48. The sequences of
both DNA strands were determined using the same prim-
ers as for PCR amplification.
DNA Sequencing
PCR products (500 ng) were treated with exonuclease
I and shrimp alkaline phosphatase (Amersham Life Sci-
ence), and subsequently sequenced using a DYEnamic
ET-terminator cycle sequencing premix kit (Amersham
Pharmacia Biotech) on an ABI 377 DNA sequencer. For
the direct sequencing of BAC DNA, we used a BigDye-
terminator RR mix (PE Applied Biosystems).
DNA and Protein Sequence–Analysis Tools
Sequence-comparison analysis was carried out using
BLAST and FASTA. The search for protein motifs was
carried out by SMART and Pfam. PSORT II was used
to predict the subcellular localization of the proteins.
The secondary structure of the protein was predicted by
Yasunaga et al.: Multiple Otoferlin Isoforms 593
Table 1
Primers for PCR Amplification of OTOF Exons 1–19
EXON
PRIMER (5′r3′)
PRODUCT
SIZE
(bp)Forward Reverse
1 AGGCAGCGGCAGAGAAGA CTCCCAGCCCTGTCCTAT 270
2 CACGAGGTCCCATGTTGCA CGGCCAGTGCCTGGGATT 295
3 TCCCTGGGGAGCACTGG AGGTTGGGAGTGTAGGTCC 334
4 CCAAGCAGTCACAGCCCTT ACCTCGCCATGCATGAGAG 302
5 TCCAGTGAGGCAAGGGTGT CTTGGATGTCTCTCCAGAAG 434
6 TCTGCAGACCTAGGCTTGC CGACAGCCCACTCCTGAG 334
7 TTCTCTCATGTTTGGCTCTTC GAGGGCCACGCATCACTG 304
8 TAACTCTCAGCTTTCTGGATG TACCCAAATTCCAATCATGGC 303
9 GTGCTTGAGTGTTTAAAGACC AGTATAGTGGATAATGCACATC 265
10 CAGATGAGAGGCAGTGGTC GCTCCTTGACTTCCAGCCA 385
11 AGGGAGGGGCCCAACACT CTCTTTATCATGGGTCTAGAC 239
12 TCCCACTTCACCACAAAGCT ACAGTCGCCAGACTGTGGT 301
13 GACAGCATTTGGTTCTGCCA GTGGCAGGTGCTCTCAGC 351
14 GTGCCAGGACCCAGGAGT TGATTTCCAGCCTTGTCTTAC 387
15 TCCCACGCCCTCACCTGT TGAAGAGAGGGCATCTCACA 302
16 TCAGCACCCAGGAGCTGG CCTGGGACCCAGGTGACT 408
17 CGGCCTGTCTGTGAGACG GAGCCTCACACTTACCACC 290
18 AAGGCAGCACCGGATTGGA TCGCTCCAGGTAGGGCAG 371
19 TCCTCCACTCCACCAATGC CCTCTGACAGCGCCGTCT 300
the Poˆle Bio-informatique Lyonnais server. Putative en-
zyme posttranslational modification sites were predicted
using the Prosearch 2.0 program.
Results and Discussion
Characterization of Human and Murine cDNAs
Encoding Long Forms of Otoferlin
The previously characterized otoferlin 5-kb cDNA
was derived from total human fetus RNA (Yasunaga et
al. 1999). In our initial study of the otoferlin mRNA,
we had failed to detect a signal by Northern blot analysis
of poly(A) RNA from various adult human tissues.
However, upon longer exposure of the blots, we were
able to detect a 5-kb transcript in the heart, placenta,
liver, pancreas, skeletal muscle, kidney, and brain, as well
as an additional 7-kb band in the brain (data not shown).
In order to characterize the longer brain transcript, 5′-
RACE-PCR experiments were performed with primers
derived from the 5′ coding sequence of the short (5-kb)
otoferlin cDNA (see Subjects andMethods). A 5′-RACE-
PCR product extending the previous cDNA sequence
was obtained from brain mRNA, but not from heart,
kidney, or total fetus mRNA. Successive rounds of ex-
tension of the brain product permitted the reconstitution
of a 7,156-bp poly(A) cDNA sequence (GenBank
AF183185). The putative translation-initiation site was
identified at position 128 (Kozak consensus sequence
ACCAGCatgGCC [Kozak 1996]) and is preceded by an
in-frame stop codon 51 bp upstream. The initiation co-
don is followed by a 5,991-bp ORF and a 1,038-bp 3′-
UTR with a polyadenylation signal (AATAAA) at po-
sition 7146. The deduced aa sequence predicts a
1,997-aa (227 kDa) protein (fig. 1), showing 31% and
33% identity (55% and 43% similarity) with the human
dysferlin andmyoferlin sequences, respectively, and23%
identity (49% similarity) with the Caenorhabditis ele-
gans fer-1.
By RT-PCR experiments, an expression of the murine
orthologous gene, Otof, had been detected in various
tissues—including the brain and the inner ear, both in
the cochlea (the auditory organ) and in the vestibule (the
balance organ) (Yasunaga et al. 1999). By northern blot
analysis, only a 7-kb transcript was detected in the mu-
rine tissues analyzed (see Subjects and Methods, and
data not shown). We thus hypothesized that this tran-
script encodes a long form of otoferlin. The 75A2MH
otoferlin cDNA clone (Yasunaga et al. 1999), which was
expected to encode the C-terminal 205 aa of the protein,
had been identified from subtractive murine cochlear
cDNA libraries (Cohen-Salmon et al. 1997; Verpy et al.
1999). To extend this cDNA sequence, 5′- and 3′-RACE-
PCR experiments were performed on mouse fetal head
mRNA (see Subjects and Methods). The entire cDNA
sequences were eventually reconstituted by RT-PCR ex-
periments on cochlear and brain total RNA. This re-
sulted in 6,872-bp (cochlea) and 7,090-bp (brain)
poly(A) cDNA sequences (GenBank AF183183 and
AF183184). The putative translation-initiation site was
identified in an appropriate Kozak consensus site
(ACCAGCatgGCC, (Kozak 1996) at position 105, pre-
ceded by an in-frame stop codon located 66 bp up-
Table 2
OTOF Exon/Intron Boundaries
EXON
NUMBERa
SIZE
(bp)
SPLICE SITE (5′r3′)
INTRON SIZE
(kb)ACCEPTOR DONOR
1 206 ACTTTCCGAG/gtagggaagccgctgtctca 11
2 59 tatttcctctttccccacag/GGCAATCCTT CTTTGATGAG/gtaggaggcccaagactccc 8.5
3 89 agttgtccctctctccccag/ACATTTCGGT TCAGCAACAA/gtaagtgtgggatggggcag 7
4 100 gccccctctgccatccccag/GCTCATCGGG TATCATCAAG/gtgggtatgccccacggagt 2.5
5 182 caccgcctccctcccttcag/ACCAGCCTGT GCTTCCGGAG/gtaacaggcaggacccctct 6
6 45 catttcttccccctactcag/CAAAGGCAGA ACGAGCACAA/gtaggtgtcccaggcgaggg 9
7 74 tctggtggcccccctcacag/AGCCGGGAGG CAAAGACCAG/gtaggacaggtgccgcgtga 1.2
8 127 cagtctttcatcttccccag/ATGAACCGGC CCAACAAGCG/gtgagtggacgggagccctg .492
9 55 tggtacattctcttcctcag/ATCTAAGCCA GGATTACCAG/gtaggtgggcacctggaggc 7
10 132 cccccttctcctgcctgcag/GTCAGCATCA TTACAACGAG/gtcagtggccctgtggggaa 6
11 63 ctggatccttccccctccag/TACTTCGTCT CAAGATTTCG/gtgagtggggagcagcccct .383
12 82 gctgtggttctgcctgaaag/GTGATTCACT TCGCAGCCAG/gtgagtacctgcgcatggcc 5
13 160 cccacccctcatcattgcag/AGCACCAGTT ACATTGAGGG/gtgaggcccagctaccccag .8
14 187 ctggctgtatgtgctggcag/GAACTTGCTG TGGCCAGAAG/gtactggggtatgaggtaca .9
15 187 tgtgctcccccttccaccag/GGCAAGACTT GGAGACAAAG/gtcagcagcgggagacccgg 1.397
16 224 ttttgttcccactgccacag/GCTTCCTGCC CATCTCGGAG/gtgagaccccaggcactgtg .474
17 109 tttgaactgcctccccacag/AGCTGTGCAG GTCACCATAG/gtgagtgctgggcccacggg .548
18 181 ctgggcccattctgctccag/GCAACTATGG TCACCGACAG/gtgggcccagcctcccatcc .081
19 121 cccgcctctgcccaccccag/GAACTACTTC CGACAAGCTG/gtcagggccaggccaggggc 1.512
5′UTRsf1b 199 AGATCATGAG/gtccctcactctcctgatca
20 101 cccacactcctgattcacag/GAAGAAGGCC GTGGCTGCTG/gtgagaagggaggggcggca .142
21 91 ccggctcgccctacccccag/CCGCTTCCTC GAGGGAGCTG/gtgaggacgcaactggacgg .127
22 117 tgacaccccctccttcgcag/GAAAACATGG GGCGGACGAG/gtgcggcccaaggggtcggg .128
23 153 ggccaccccccaacccccag/CCCCAGCACA CTTCCTTAAG/gtgctggagggggcaggatg .549
24 190 gaccccatgcccacccccag/CTGCCAGGGA GTCTACACCA/gtgagtgaggacccctcact .089
25 125 caggctgcccttccccacag/AGAAGCAGGC GTGCACAGAG/gtgagggcctgggaggaggg .42
26 135 ctccccatcccatgctgcag/GTGCTGAATG GGATTCCATG/gtatgggtgggctctggtgc .684
27 162 tgggttgtctgttgcgtcag/GGCAAAGCTG GCTGCTGCAG/gtgggactgcagggaagagg .402
28 120 ctgtgacccccattccccag/ATTGGACCAG CCGAGTGGAG/gtgcgagggctctgtgtggc .426
29 162 caccctccaacctctcccag/GTGCTGTTCT GTTTGAAGTG/gtgagtgcaggccctggcgg .111
30 163 tcctgtcgccaacaccccag/GACCTCCCAG AACACCACGG/gtatggccacatccaccctg .482 (.542)
31c 131 ccatctatccatctgtccag/TCAGGCTTCT GCTGGACGCG/gtaaggcgggtggggtcagc
ctcctcctctcactccacag/GGGAGGTTGT 1.369
32 30 tctccttggttcctctgcag/ACTTCTGAAG GGTGGATGTG/gtgagtgtgggggccatgca .399
33 129 tggacctggccaacctgcag/GCTGAGGAGG CATGAAGGAG/gtgagacctcgggtagggtg 2.119
34 67 ttcatctcatcttttggcag/CAACTTCGAC AATACCGAGG/gtgagccctggaacctggaa .905
35 137 ccttttctgcttctggccag/GCCTGAAGGG TGAGCTTAAG/gtgagagcctaggagcagac .131
36 135 aacagcctggtctgtctcag/GTATACCCCA ACGCTTCAAG/gtcaggccaggagcacgggc .247
37 138 cccacatttgtcttgcccag/GGCTCCCTCT TGTGGTCCGG/gtgagactcccgtcgctttc .637
38 128 agcccttctccccattccag/GCCACGGACC TCTTTGGGAA/gtaaggcttcttggtgccct .106
39 171 tcctaactccaccccaccag/GTCCTTTGAC CCTACTCCAC/gtatgtggggcatggggcag .642
40 161 ctgtgtgtcccctcccacag/ACATGGCTAC GACGAGAACG/gtaatggggcactggatgca .766
41 143 tgagccgccggcacccacag/GTCAGAGGAA CATCGAGCAG/gtgacacttgcatggccaag .392
42 89 gccacaaccctcttcctcag/GGCCGCCTGG AGCCCAAGAA/gtgagcggcctggggcccag 1.287
43 99 ccttctctccctgggcccag/GTACGAGCTG TCGTGAGGGG/gtgggtgagcagtccctgca .145
44 242 tggagatgtggcgcccacag/GTGGCTGAAG GACTTCCTGG/gtgcagagcagggcagggat .664
45 179 tgacactgaggttgccacag/GGGCCATCGA TGAGCTCACG/gtgcgcaccccttcctgctc .104
46 101 gacctgtctgtcctctgcag/GGCAAGGTGG AGAAACCCAA/gtgagtgccctgccggccca .441
47 198 ctctacccttcatactccag/CCGGCCCGAC GGCCTCCTGG/gtctgatatttcttacttct 1.695
48 1018 tcctctcttccacttcccag/CCGGCCCGAC
a Exons 20–47 were referred to as exons 1–28 in Yasunaga et al. (1999).
b “5′UTRsf1” refers to an additional exon which corresponds to the 5′-untranslated region of the transcript encoding
the otoferlin short form 1 and encodes the predicted first 17 aa of the short form 2 (see fig. 3).
c Exon 31 contains an alternative acceptor splice site at nucleotide position 61 (see fig. 4B).
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Figure 1 Deduced amino acid sequence of human otoferlin brain
long isoform. The predicted C-terminal transmembrane domain is in-
dicated in boldface; the six C2 domains are underlined; the five aspartyl
residues (D) that presumably bind Ca2 in each of the last four C2
domains (Sutton et al. 1995; Rizo and Su¨dhof 1998) are in boldface.
stream. The initiation codon is followed by a 5,976-bp
(cochlea) or 5,991-bp (brain) ORF, and a 792-bp (coch-
lea) or 995-bp (brain) 3′-UTR with a polyadenylation
signal (AATAAA) at position 6856 (cochlea) or 7074
(brain). These cDNAs encode predicted 1992 aa (coch-
lea) and 1997 aa (brain) proteins, showing 95% of se-
quence identity (98% similarity) with the human oto-
ferlin. RACE-PCR experiments failed to detect short
cDNA forms in all the murine tissues tested, namely the
cochlea, vestibule, brain, and testis.
Analysis of the deduced sequences of the human and
murine otoferlins showed the presence of a C-terminal
transmembrane (TM) domain (see fig. 2) and the absence
of a leader peptide or subcellular targeting signal. Six
fragments with homology to C2 domains (C2A-F) were
recognized (figs. 1 and 2) using SMART and Pfam pro-
grams. C2 domains are composed of two four-stranded
b sheets and have highly similar structures (Sutton et al.
1995; Rizo and Su¨dhof 1998). The extensive analysis of
the C2A domain of rat synaptotagmin-1 (Syt-1 C2A)
has permitted the recognition of five aspartyl residues
which bind Ca2; two are located in the loop between
b strands 2 and 3, and three are located in the loop
between b strands 6 and 7. The C2A domain of otoferlin
is incomplete (the b1 strand is missing as in dysferlin)
and both C2A and C2B domains lack several of the five
aforementioned aspartyl residues. The amino acid se-
quences of the C2A and C2B domains show 16% and
30% identity (28% and 46% similarity) with that of
Syt-1 C2A, respectively. The C2C domain is a full C2
domain, with the five aspartyl residues predicted to bind
Ca2 being conserved. This domain shows 29% iden-
tity (40% similarity) with Syt-1 C2A. The subsequent
three C2 domains are also complete domains predicted
to bind Ca2 (Yasunaga et al. 1999). Therefore, as in
myoferlin and dysferlin, only the last four C2 domains
of otoferlin are predicted to bind Ca2. The C2 domain-
containing proteins are known to interact with phos-
pholipids and proteins. In addition, synaptotagmins,
rabphilin 3A, munc 13, DOC2, and RIM, all of which
possess C2 domains, are involved in the docking of the
synaptic vesicles to the plasma membrane and/or their
fusion (Rizo and Su¨dhof 1998). Along the same line,
even though the function of fer-1 in C. elegans is not
yet entirely elucidated, this protein seems to be required
for the final step of the fusion between vesicles and the
plasma membrane (Achanzar and Ward 1997). On the
basis of these data and the presence of the otoferlin
transcript in the sensory hair cells of the inner ear (Ya-
sunaga et al. 1999), we hypothesized that otoferlin is
involved in the Ca2-triggered synaptic vesicle-plasma
membrane fusion. No other domain of homology with
known proteins could be identified in the otoferlin de-
duced sequences. Finally, by use of the Prosearch 2.0
program, several putative phosphorylation sites for
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Figure 2 Schematic representation of the human otoferlin (long and short forms), myoferlin, dysferlin, and nematode fer-1. The six C2
domains of otoferlin (long form) are designated C2A (aa 1–97), C2B (aa 254–352), C2C (aa 417–528), C2D (aa 960–1067), C2E (aa 1493–1592),
and C2F (aa 1733–1863). Asterisks (*) indicate the C2 domains expected to bind Ca2.
cAMP-dependent protein kinase (5–7), casein kinase II
(42–43), tyrosine kinase (4) and protein kinase C
(29–31), and 9–11 putative N-glycosylation sites were
predicted in the murine and human sequences.
Exon-Intron Structure of the Human and Murine
Otoferlin Genes
To determine the exon/intron boundaries and to es-
timate the size of the introns, long-range PCR amplifi-
cations were performed on genomic DNA using primers
selected within the cDNA sequences, and the PCR prod-
ucts were directly sequenced. Direct sequencing on BAC
(bacterial artificial chromosome) DNA was also per-
formed (on human BAC clone 93m21 and murine BAC
clone 233j15). From the comparative analysis of the ge-
nomic sequence and the sequence of the various cDNA
isoforms that were identified (see below), we were able
to conclude that the human OTOF and murine Otof
are both composed of 48 coding exons. The first and
last exons also encode the 5′-UTR and 3′-UTR, respec-
tively. OTOF and Otof extend over 90 kb and 80 kb,
respectively (fig. 3). The exon-intron junctions of the
human gene are listed in table 2. All the splice sites
follow the GT/AG rule (Shapiro and Senapathy 1987).
In addition, specific primers flanking each OTOF exon
from exon 1 to exon 19 were designed (table 1), hence-
forth allowing sequence analysis of the 48 exons of the
gene (see also Yasunaga et al. 1999) for a mutation
search in DFNB9-affected individuals (see below).
Multiple Otoferlin Isoforms Predicted from
Alternatively Spliced Transcripts
In the human brain, in addition to the otoferlin short
cDNA (5 kb) initially reported in the fetus (Yasunaga et
al. 1999) (GenBank AF107403) and referred to as hu-
man short form 1 in fig. 3, we isolated another, slightly
longer cDNA (GenBank AF183186) which differs by its
5′ region (human short form 2 in fig. 3). In this form,
the initiation codon identified within a weak Kozak con-
sensus (TTCCTCatgATG) is preceded by an in-frame
stop codon 57 bp upstream. The corresponding pre-
dicted protein of 1,307 aa (149 kDa), possesses 57 ad-
ditional aa in the N-terminal region, which does not
present any similarity with known proteins. From the
analysis of the genomic sequence, we could conclude that
this form results from use of both the 3′ part of exon
5′-UTR sf1 (for 5′ untranslated region of short form 1)
and the following optional intron (i.e., used as an intron
in short form 1), to encode the predicted 57 additional
aa of the protein (fig. 3) (table 2). The absence of a
detected short form (i.e., encoded by exons 20–48) of
the otoferlin transcript in the mouse deserves further
comment. No open reading frame was found in the mu-
rine genomic sequence corresponding to the human 5′-
UTR sf1 additional exon and following intron, which
is evidence against the existence of a murine equivalent
of the human brain otoferlin short form 2 (see fig. 3).
Moreover, even though the human putative translation
initiation site of exon 20 is conserved in the mouse, no
appropriate donor splice-site consensus sequence could
be predicted within murine intron 19, strongly suggest-
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Figure 3 Schematic representation of the OTOF exon-intron
structure (top) and detail of the genomic region encompassing exons
18–22 in humans and in mice (bottom). The exonic sequences found
in the three different human transcripts (long form and short forms 1
and 2) and in the single murine long transcript are boxed. Thepredicted
coding sequences are indicated by blackened boxes, the untranslated
regions by unblackened boxes.
Figure 4 Alternative splicings of the Otof exons 6, 31, and 47
in the murine brain and cochlea. The genomic regions encompassing
exons 5–7 (A), exons 30–32 (B) and exons 46–48 (C) are schematized.
The exonic sequences found in the different murine transcripts are
boxed. The coding regions are indicated by blackened boxes, the un-
translated regions by unblackened boxes.
ing that a type 1 short form of otoferlin (fig. 3) does not
exist either.
Interestingly, several alternatively spliced long forms
of otoferlin transcripts were detected in both mice and
humans. Firstly, in the murine brain and cochlea, cDNAs
were found that resulted from the skipping of exon 6
(fig. 4A). Exon 6 encodes 15 aa located in the N-terminal
part of the first inter-C2 domain region (aa 169–184 in
the murine cochlear form [GenBank AF183183]). RT-
PCR experiments on human brain RNA also revealed a
single product that resulted from the skipping of exon
6 (data not shown). Secondly, RT-PCR analysis of the
cDNA sequence corresponding to exon 31 in the murine
brain and cochlea, revealed two different products re-
sulting from the alternative use of an acceptor splice site
within exon 31 (table 2) (fig. 4B). The same results were
obtained in the human brain (GenBank AF183186). By
contrast, in the human heart, kidney, and total fetus,
only the shorter PCR product corresponding to the use
of the internal splice site was detected (data not shown).
The additional 20 aa encoded by the 5′ part of this exon
belong to the fourth inter C2 domain region (aa position
1244–1264 in the murine brain sequence GenBank
AF183184, and aa position 1245–1265 in the human
brain sequence [GenBank AF183185] [fig. 1]). Finally,
RT-PCR experiments performed on the murine brain
RNA showed the use of exon 47 (encoding the most C-
terminal 60 aa) in the otoferlin transcript (fig. 4C),
whereas similar experiments performed on the cochlear
RNA revealed the skipping of exon 47, and the use of
the 5′ part of exon 48 to encode the C-terminal 60 res-
idues (fig. 4C). The murine exon 47 and the 5′ part of
exon 48 are expected to code for highly similar 60 aa
peptides (fig. 5). The human and murine peptides en-
coded by exon 47 differ by only 5 aa and those encoded
by exon 48 by 1 aa. As in the murine cochlea, exon 47
was found to be skipped in the otoferlin cDNAs isolated
from the human adult heart, kidney, and total fetus (data
not shown).
Here, we present evidence for two classes of otoferlin
isoforms: the long ones, with six C2 domains and a C-
terminal TM domain, and the short ones, containing
only the last three C2 domains and the TM domain. In
murine tissues, only transcripts encoding long isoforms
could be detected, whereas, in human tissues other than
the brain, only short forms could be identified. At pre-
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Figure 5 Comparison between the deduced amino acid sequences encoded by exons 47 and 48 in humans and in mice. The predicted
transmembrane domains are underlined. Identical residues are indicated by vertical bars and similar residues by colons.
Figure 6 A, Pedigree of the nuclear family J2. B, Sequence anal-
ysis of the OTOF intron 8–exon 9 junction showing the ArG sub-
stitution (ISV8-2ArG) at the invariant AG dinucleotide of the acceptor
splice-site (arrowhead). Top, middle, and bottom electrophoregrams
correspond to a control individual, heterozygous carrier (III-1), and
affected individual (IV-3), respectively.
sent, the basis of this difference is enigmatic. So far, no
short forms of either dysferlin or myoferlin have been
reported (Bashir et al. 1998; Liu et al. 1998; Davis et
al. 2000). However, a 542-aa truncated form of my-
oferlin comprising the first three C2 domains and devoid
of a TM domain has been predicted (Davis et al. 2000).
In the brain, both in mice and humans, the long isoforms
of otoferlin are predicted to lack part of the first inter
C2 domain and to contain a TM domain encoded by
exon 47. The murine transcripts may or may not contain
a region of the fourth inter C2 domain encoded by the
5′ end of exon 31. In the murine cochlea, the two pre-
dicted long isoforms contain the part of the first inter
C2 domain encoded by exon 6, a C-terminal end en-
coded by exon 48 and differ by the presence/absence of
the region of the fourth inter C2 domain encoded by
the 5′ end of exon 31. The presence of the several C2
domains indicates for multiple molecular interactions of
otoferlin. In particular, the use of either exon 47 or exon
48 to encode the last 60 aa of this protein most likely
has a functional significance, and may underlie mem-
brane targeting of the protein to different cell compart-
ments and/or interaction with different ligands. In this
regard, it is noteworthy that although a single trans-
membrane domain sequence has so far been reported in
myoferlin, the protein has been detected as associated
with both the nuclear and the cytoplasmic membranes
(Davis et al. 2000).
Novel OTOF Mutation Affecting the Long Isoforms in
an Indian Family Affected by DFNB9
The nonsense mutation detected in the Lebanese con-
sanguineous families (Yasunaga et al. 1999) is predicted
to truncate the 500 C-terminal amino acids common to
the short and long otoferlin putative isoforms. This does
not permit a conclusion about the implication of one or
the other types of otoferlin isoforms in the hearing loss.
We analyzed a consanguineous family originating
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from India (family J2) in which three siblings suffered
from severe-to-profound hearing loss (fig. 6A). Segre-
gation analysis with polymorphic markers of the DFNB9
chromosomal region (see Subjects andMethods) allowed
us to conclude that an OTOF mutation was likely to
underlie deafness in this family (data not shown). The
48 OTOF coding exons were sequenced in the three
affected individuals (IV-3, IV-4, IV-5), their unaffected
sister (IV-2), and their parents (III-1, III-2). A homozy-
gous ArG substitution at the intron 8/exon 9 junction
(IVS8-2ArG) was detected in the three affected siblings.
The same substitution was found at the heterozygous
state in the parents and the unaffected siblings (fig. 6B).
This mutation affects the invariant A of the AG acceptor
splice site and was not detected in 109 DNAs (218 al-
leles) collected from random individuals in southwestern
India. This establishes that IVS8-2ArG is the causative
mutation for deafness in family J2. The mutation is ex-
pected to lead to aberrant splicing, such as the skipping
of the 55-bp-long exon 9, creating a premature stop
codon in exon 10. This result demonstrates that the ex-
pression of the long otoferlin isoforms is required for
the auditory function in humans. We have previously
shown that, in the inner ear, Otof is only expressed by
the sensory hair cells and, in adults, predominantly by
the inner hair cells. The next step will be to clarify the
role of each of the predicted otoferlin isoforms—and, in
particular, the long ones—with regards to the function-
ing of the hair cells.
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